NCT03529110 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 261
- group Id
- BG001
- value
- 263
- group Id
- BG002
- value
- 524
- units
- Participants
- groups
- description
- Participants with HER2-positive, unresectable and/or metastatic breast cancer participants previously treated with trastuzumab and taxane who received T-DXd as a sterile intravenous (IV) solution at a dose of 5.4 mg/kg every 3 weeks (Q3W).
- id
- BG000
- title
- Trastuzumab Deruxtecan (T-DXd)
- description
- Participants with HER2-positive, unresectable and/or metastatic breast cancer participants previously treated with trastuzumab and taxane who received T-DM1 in accordance with the approved label.
- id
- BG001
- title
- Ado-trastuzumab Emtansine (T-DM1)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 212
- group Id
- BG001
- value
- 206
- group Id
- BG002
- value
- 418
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 106
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.11
- value
- 54.5
- group Id
- BG001
- spread
- 11.84
- value
- 54.2
- group Id
- BG002
- spread
- 11.47
- value
- 54.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 262
- group Id
- BG002
- value
- 522
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 152
- group Id
- BG001
- value
- 162
- group Id
- BG002
- value
- 314
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 19
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 71
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 143
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 46
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- Baseline characteristics were assessed using the Full Analysis Set.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 261
- group Id
- BG001
- value
- 263
- group Id
- BG002
- value
- 524
- units
- Participants
- groups
- description
- Participants with HER2-positive, unresectable and/or metastatic breast cancer participants previously treated with trastuzumab and taxane who received T-DXd as a sterile intravenous (IV) solution at a dose of 5.4 mg/kg every 3 weeks (Q3W).
- id
- BG000
- title
- Trastuzumab Deruxtecan (T-DXd)
- description
- Participants with HER2-positive, unresectable and/or metastatic breast cancer participants previously treated with trastuzumab and taxane who received T-DM1 in accordance with the approved label.
- id
- BG001
- title
- Ado-trastuzumab Emtansine (T-DM1)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 212
- group Id
- BG001
- value
- 206
- group Id
- BG002
- value
- 418
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 106
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.11
- value
- 54.5
- group Id
- BG001
- spread
- 11.84
- value
- 54.2
- group Id
- BG002
- spread
- 11.47
- value
- 54.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 260
- group Id
- BG001
- value
- 262
- group Id
- BG002
- value
- 522
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 152
- group Id
- BG001
- value
- 162
- group Id
- BG002
- value
- 314
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 19
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 71
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 143
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 46
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- Baseline characteristics were assessed using the Full Analysis Set.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle